Signature HealthCARE has launched a collaboration with Dialyze Direct to provide on-site hemodialysis for patients with ESRD who reside in short-term, long-term and rehabilitation facilities, according to a press release from Signature HealthCARE.
Dialyze Direct’s shorter, more frequent in-center treatment offers an alternative to traditional dialysis. The Dialyze Direct treatment model offers dialysis 5 days per week for 2.5 hours rather than the typical 3 days per week with 4- to 5-hour sessions. Typical recovery time with the model is 30 to 60 minutes compared with 8 to 9 hours for conventional dialysis. In-center hemodialysis has been shown to decrease hospitalization and mortality rates associated with dialysis, according to the release.
Signature HealthCARE hopes this partnership will improve quality of life while lowering stress and costs for patients at nursing facilities.
“The Dialyze Direct approach to the treatment of ESRD is truly a new generation option that supports the national focus of providing the right care, at the right place, at the right time, in a way that reduces the cost of care while improving the experience of those being served,” George Burkley, chief strategy officer of Signature HealthCARE, said in the release.
After the acquisition of Affiliated Dialysis Centers in February, Dialyze Direct became the largest provider of staff-assisted hemodialysis treatment in nursing homes in the United States. The acquisition strengthened Dialyze Direct’s hold on the Midwest market.
With a letter of intent in place, Signature HealthCARE has instituted pilot programs in two of its 115 locations and is continuing to expand the collaboration. At each location, Dialyze Direct works with the nursing team, rehabilitation team and nephrologists to create unique care plans for patients.
“Improving dialysis patient outcomes will enable Signature HealthCARE to spend more of their time focusing on core therapies, rather than the complications that arise as a result of traditional outpatient dialysis,” Burkley said in the release.